Skip to main
CME

CME Group (CME) Stock Forecast & Price Target

CME Group (CME) Analyst Ratings

Based on 12 analyst ratings
Buy
Strong Buy 25%
Buy 33%
Hold 33%
Sell 8%
Strong Sell 0%

Bulls say

CME Group reported total revenue of $1,649 million, reflecting an approximate 8.1% year-over-year increase, primarily driven by strong demand in its Market Data segment, which grew around 14.5% year-over-year. The company has demonstrated robust free cash flow generation, allowing it to consistently increase quarterly dividend payments for over 14 consecutive years, indicating a solid commitment to returning value to shareholders. Additionally, CME has successfully achieved a compound annual growth rate of over 7% in average daily volume from FY16 through FY24, supported by heightened customer demand and ongoing product innovation, further enhancing the company's revenue potential.

Bears say

CME Group faces a negative outlook primarily due to anticipated declines in interest rate futures trading volume resulting from an impending rate-cutting cycle, alongside increased competition from alternative exchanges. Projections indicate a revenue growth of approximately 5.4% year-over-year to around $6,872 million, which falls short of consensus expectations of 6.0% growth, exacerbating concerns over pricing pressures and limited margin improvements. Additionally, regulatory risks, including potential increases in margin requirements and trading limitations, pose further threats to trading volume and overall company performance.

CME Group (CME) has been analyzed by 12 analysts, with a consensus rating of Buy. 25% of analysts recommend a Strong Buy, 33% recommend Buy, 33% suggest Holding, 8% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of CME Group and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About CME Group (CME) Forecast

Analysts have given CME Group (CME) a Buy based on their latest research and market trends.

According to 12 analysts, CME Group (CME) has a Buy consensus rating as of Apr 4, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $302, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $302, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

CME Group (CME)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.